Phase 3 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 70 years of age
- People with a laboratory-confirmed diagnosis of nasopharyngeal carcinoma (a type of cancer at the back of the nose and throat), specifically WHO type II or III
- People whose cancer is classified as high-risk locally advanced disease, meaning it has reached a stage called T4 or N3 but has not spread to distant parts of the body (confirm staging details with trial site)
- People who have not yet received any treatment for nasopharyngeal carcinoma, including radiation, chemotherapy, targeted therapy, or immunotherapy
- People with a good general level of physical functioning, rated 0 or 1 on a standard medical scale where 0 means fully active and 1 means minor limitations (confirm with trial site)
- People whose heart, liver, kidneys, and other organs are working well enough to meet the study's health requirements (confirm specific values with trial site)
- People whose treating doctor determines they are suitable to receive the combination of chemotherapy and radiation with immunotherapy used in this trial
- People who are willing and able to read and sign a consent form agreeing to take part
Who may not be able to join:
- People whose cancer has already spread to distant parts of the body
- People who have already received any form of treatment for nasopharyngeal carcinoma
- People who have an active autoimmune disease that currently requires ongoing medical treatment
- People with an uncontrolled infection or serious health conditions that could make tolerating the treatment difficult
- People who are pregnant or currently breastfeeding
- People with a known allergy, severe sensitivity, or medical reason to avoid any of the medications used in this study (confirm specifics with trial site)
- People who, in the trial doctor's judgment, have any other condition that makes participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of treatment-related grade ≥3 acute toxicities; 3-year Progression-Free Survival (PFS) Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.